187 related articles for article (PubMed ID: 9139077)
1. Use of polymerase chain reaction to provide prognostic information on human cytomegalovirus disease after liver transplantation.
Lao WC; Lee D; Burroughs AK; Lanzani G; Rolles K; Emery VC; Griffiths PD
J Med Virol; 1997 Mar; 51(3):152-8. PubMed ID: 9139077
[TBL] [Abstract][Full Text] [Related]
2. Monitoring transplant patients for human cytomegalovirus: Diagnostic update.
Gerna G; Lilleri D
Herpes; 2006 May; 13(1):4-11. PubMed ID: 16732996
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
Hebart H; Rudolph T; Loeffler J; Middeldorp J; Ljubicic T; Jahn G; Einsele H
Bone Marrow Transplant; 2002 Aug; 30(3):181-7. PubMed ID: 12189537
[TBL] [Abstract][Full Text] [Related]
4. Monitoring human cytomegalovirus (HCMV) in HCMV-seropositive orthotopic liver-transplant recipients by means of quantitative real-time polymerase chain reaction.
Mengelle C; Abravanel-Legrand F; Kamar N; Alain S; Basse G; Pillet A; Lavayssière L; Suc B; Izopet J; Rostaing L
Exp Clin Transplant; 2006 Dec; 4(2):537-43. PubMed ID: 17238855
[TBL] [Abstract][Full Text] [Related]
5. Impact of human cytomegalovirus infection UL55-nested polymerase chain reaction method in hematopoietic stem cell transplant donors and recipients.
Banan AA; Yaghobi R; Ramzi M; Mehrabani D
Transplant Proc; 2009 Sep; 41(7):2898-9. PubMed ID: 19765467
[TBL] [Abstract][Full Text] [Related]
6. Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation.
Peggs KS; Preiser W; Kottaridis PD; McKeag N; Brink NS; Tedder RS; Goldstone AH; Linch DC; Mackinnon S
Br J Haematol; 2000 Dec; 111(3):782-90. PubMed ID: 11122138
[TBL] [Abstract][Full Text] [Related]
7. Relationship between IgM antibody to human cytomegalovirus, virus load, donor and recipient serostatus, and administration of methylprednisolone as risk factors for cytomegalovirus disease after liver transplantation.
Emery VC; Cope AV; Sabin CA; Burroughs AK; Rolles K; Lazzarotto T; Landini MP; Brojanac S; Wise J; Maine GT
J Infect Dis; 2000 Dec; 182(6):1610-5. PubMed ID: 11069231
[TBL] [Abstract][Full Text] [Related]
8. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation.
Westall GP; Michaelides A; Williams TJ; Snell GI; Kotsimbos TC
Transplantation; 2003 Jun; 75(12):2064-8. PubMed ID: 12829913
[TBL] [Abstract][Full Text] [Related]
9. Monitoring HCMV infection with quantitative real-time PCR in HCMV-positive orthotopic liver transplant recipients, and predictive factors for treatment of the first episode of HCMV viremia.
Pillet A; Mengelle C; Basse G; Ribes D; Kamar N; Muscari F; Lavayssière L; Suc B; Esposito L; Peron JM; Rostaing L
Transplant Proc; 2006 Sep; 38(7):2335-8. PubMed ID: 16980083
[TBL] [Abstract][Full Text] [Related]
10. [Direct detection of human cytomegalovirus in urine specimens from bone marrow transplant patients by polymerase chain reaction].
Ohshima T; Miyachi H; Fusegawa H; Tanaka S; Yabe H; Yabe M; Kato S; Ando Y
Rinsho Byori; 1996 Mar; 44(3):267-73. PubMed ID: 8857170
[TBL] [Abstract][Full Text] [Related]
11. A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients.
Madan RP; Campbell AL; Shust GF; Kahn AR; Wistinghausen B; Posada R; Kerkar N; Shneider BL; Emre S; Herold BC
Transplantation; 2009 May; 87(9):1318-24. PubMed ID: 19424031
[TBL] [Abstract][Full Text] [Related]
12. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
[TBL] [Abstract][Full Text] [Related]
13. Clinical usefulness of human cytomegalovirus antigenemia assay after kidney transplantation.
Kim CK; Song JH; Kim SM; Peck KR; Oh W; Huh W; Kim YG; Kim SJ; Joh JW; Lee NY; Park CG; Hwang ES; Cha CY; Oh HY
Transplantation; 2003 Jun; 75(12):2151-5. PubMed ID: 12829929
[TBL] [Abstract][Full Text] [Related]
14. Follow-up of 28 HCMV seropositive renal-transplant recipients: comparison of clinical, biological and virological parameters in the groups of treated versus untreated infected patients.
Kamar N; Mengelle C; Yahyaoui S; Sandres-Sauné K; Durand D; Izopet J; Rostaing L
J Clin Virol; 2005 May; 33(1):35-42. PubMed ID: 15797363
[TBL] [Abstract][Full Text] [Related]
15. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the COBAS Amplicor HCMV Monitor for early detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
Lengerke C; Ljubicic T; Meisner C; Loeffler J; Sinzger C; Einsele H; Hebart H
Bone Marrow Transplant; 2006 Jul; 38(1):53-60. PubMed ID: 16788683
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal monitoring of latent and active human cytomegalovirus infections in peripheral blood of heart transplant recipients by single-tube nested RT-PCR.
Wolff D; Skourtopoulos M; Hörnschemeyer D; Wolff C; Körner M; Körfer R; Kleesiek K
Microbiol Res; 1996 Dec; 151(4):343-9. PubMed ID: 9022299
[TBL] [Abstract][Full Text] [Related]
18. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
[TBL] [Abstract][Full Text] [Related]
19. Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group.
Emery VC; Sabin C; Feinberg JE; Grywacz M; Knight S; Griffiths PD
J Infect Dis; 1999 Sep; 180(3):695-701. PubMed ID: 10438356
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and monitoring of human cytomegalovirus infection in bone marrow transplant recipients by quantitative competitive PCR.
Ziyaeyan M; Sabahi F; Alborzi A; Mahboudi F; Kazemnejad A; Ramzi M; Moravej A; Jaberi MM
Exp Clin Transplant; 2006 Jun; 4(1):470-4. PubMed ID: 16827646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
